No Data
Telix Pharmaceuticals Says FDA Clears Path to Advance Phase 3 Study of Prostate Cancer Drug Candidate
Telix Gets FDA Alignment on Prostate Cancer Trial Expansion to US
Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (EVMN) and Telix Pharmaceuticals (OtherTLPPF)
The ASX Today: Tech Leads Bourse as Neuren Surges on Major European Approval Boost
EchoIQ Limited (EIQ) Receives a Buy From Bell Potter
The Short Report – 25 Jun 2026
151443091 : 30 by september
SamGallamore 151443091 : mid 20’s is my call